Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karima Mokhtari

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neuropathology and Experimental Neurology|May 25, 2020
Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective StudyGuillaume Gauchotte, Matthieu Peyre, Celso Pouget, et al.
The Oncologist|July 13, 2016
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated GliomasMarianne Labussière, Amithys Rahimian, Marine Giry, et al.
Journal of Neurosurgery|April 22, 2004
Prognostic value of allelic losses and telomerase activity in meningiomasPascal Leuraud, Edouard Dezamis, Lucinda Aguirre-Cruz, et al.
Cancer Investigation|January 7, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent GlioblastomaMarianne Labussière, Caroline Cheneau, Claudia Prahst, et al.
Journal of Neuro-Oncology|April 21, 2022
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomesChristelle Nilles, Daniel Delgadillo, Marie Sarazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasMarc Sanson, Yannick Marie, Sophie Paris, et al.
Neuro-Oncology|October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohortDomique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Neurology|August 24, 2014
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarianne Labussière, Blandine Boisselier, Karima Mokhtari, et al.
Journal of Neuropathology and Experimental Neurology|November 4, 2016
Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free SurvivalCatherine Ling, Celso Pouget, Fabien Rech, et al.
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
Cancer|March 29, 2006
Prognostic impact of molecular markers in a series of 220 primary glioblastomasCaroline Houillier, Julie Lejeune, Alexandra Benouaich-Amiel, et al.
Journal of Neuropathology and Experimental Neurology|May 25, 2020
Prognostic Value of Histopathological Features and Loss of H3K27me3 Immunolabeling in Anaplastic Meningioma: A Multicenter Retrospective StudyGuillaume Gauchotte, Matthieu Peyre, Celso Pouget, et al.
The Oncologist|July 13, 2016
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated GliomasMarianne Labussière, Amithys Rahimian, Marine Giry, et al.
Journal of Neurosurgery|April 22, 2004
Prognostic value of allelic losses and telomerase activity in meningiomasPascal Leuraud, Edouard Dezamis, Lucinda Aguirre-Cruz, et al.
Cancer Investigation|January 7, 2016
Angiopoietin-2 May Be Involved in the Resistance to Bevacizumab in Recurrent GlioblastomaMarianne Labussière, Caroline Cheneau, Claudia Prahst, et al.
Journal of Neuro-Oncology|April 21, 2022
Primary CNS lymphoma of the corpus callosum: presentation and neurocognitive outcomesChristelle Nilles, Daniel Delgadillo, Marie Sarazin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2009
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomasMarc Sanson, Yannick Marie, Sophie Paris, et al.
Neuro-Oncology|October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohortDomique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Neurology|August 24, 2014
Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classesMarianne Labussière, Blandine Boisselier, Karima Mokhtari, et al.
Journal of Neuropathology and Experimental Neurology|November 4, 2016
Endothelial Cell Hypertrophy and Microvascular Proliferation in Meningiomas Are Correlated with Higher Histological Grade and Shorter Progression-Free SurvivalCatherine Ling, Celso Pouget, Fabien Rech, et al.
Pageof 21